Larimar Therapeutics (LRMR) Receivables - Other (2023 - 2025)
Larimar Therapeutics (LRMR) posted Receivables - Other of $747000.0 for Q4 2025, down 25.37% on a QoQ basis from $1.0 million in Q3 2025, and down 29.13% year-over-year from $1.1 million in Q4 2024.
Larimar Therapeutics (LRMR) Receivables - Other (2023 - 2025) Analysis & Trends
Larimar Therapeutics' Receivables - Other history runs 3 years deep, the most recent figure standing at $747000.0 for Q4 2025.
- Quarterly Receivables - Other fell 29.13% year-over-year to $747000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $747000.0 (down 29.13% YoY) and the FY2025 annual result came in at $747000.0, down 29.13% from the prior year.
- Receivables - Other was $747000.0 for Q4 2025 at Larimar Therapeutics, down from $1.0 million in the prior quarter.
- Across five years, Receivables - Other topped out at $1.1 million in Q1 2024 and bottomed at $332000.0 in Q4 2023.
- A 3-year average of $882888.9 and a median of $983000.0 in 2025 frame the typical range for Receivables - Other.
- Annual changes were most pronounced in 2024 — Receivables - Other soared 217.47% — and 2025, when it retreated 29.13%.
- Larimar Therapeutics' Receivables - Other stood at $332000.0 in 2023, then surged by 217.47% to $1.1 million in 2024, then slipped by 29.13% to $747000.0 in 2025.
- Business Quant data shows LRMR's Receivables - Other at $747000.0 in Q4 2025, $1.0 million in Q3 2025, and $983000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Larimar Therapeutics | 37.00 Mn | -99.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 747,000.00 |
| Dec 31, 2025 | 747,000.00 |
| Sep 30, 2025 | 1.00 Mn |
| Sep 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 983,000.00 |
| Jun 30, 2025 | 983,000.00 |
| Mar 31, 2025 | 1.06 Mn |
| Mar 31, 2025 | 1.06 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 943,000.00 |
| Sep 30, 2024 | 943,000.00 |
| Jun 30, 2024 | 751,000.00 |
| Jun 30, 2024 | 751,000.00 |
| Mar 31, 2024 | 1.08 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 332,000.00 |
| Dec 31, 2023 | 332,000.00 |